These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11283964)

  • 21. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
    Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
    Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Milanés MV
    J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats.
    Stornetta RL; Norton FE; Guyenet PG
    Brain Res; 1993 Oct; 624(1-2):19-28. PubMed ID: 7902768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
    Murphy NP; Onaka T; Brown CH; Leng G
    Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atipamezole-precipitated clonidine withdrawal induces c-Fos expression in rat central nervous system.
    Stornetta RL; Grubb MC; Guyenet PG
    Brain Res; 1997 Aug; 764(1-2):81-92. PubMed ID: 9295196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal.
    Almela P; Milanés MV; Laorden ML
    Br J Pharmacol; 2007 Jul; 151(6):787-97. PubMed ID: 17549049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions.
    Clausen TR; Møller M; Woldbye DP
    J Neurosci Res; 2001 May; 64(4):410-7. PubMed ID: 11340648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of morphine and morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla.
    Baraban SC; Stornetta RL; Guyenet PG
    Brain Res; 1995 Apr; 676(2):245-57. PubMed ID: 7542145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of PKC in regulation of Fos and TH expression after naloxone induced morphine withdrawal in the heart.
    Almela P; Cerezo M; Milanés MV; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):374-82. PubMed ID: 16474935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
    Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
    Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal.
    Zhou Q; Karlsson K; Liu Z; Johansson P; Le Grevés M; Kiuru A; Nyberg F
    Neuropharmacology; 2001 Aug; 41(2):246-53. PubMed ID: 11489461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.
    Gracy KN; Dankiewicz LA; Koob GF
    Neuropsychopharmacology; 2001 Feb; 24(2):152-60. PubMed ID: 11120397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.
    Chartoff EH; Papadopoulou M; Konradi C; Carlezon WA
    J Neurochem; 2003 Oct; 87(1):107-18. PubMed ID: 12969258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones.
    Laorden ML; Núñez C; Almela P; Milanés MV
    J Neurochem; 2002 Oct; 83(1):132-40. PubMed ID: 12358736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
    González-Cuello A; Milanés MV; Aviles M; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):17-25. PubMed ID: 15249992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.